clinical-stage biotherapeutics

ImmuneSensor Therapeutics Announces New President/CEO

by | May 3, 2024
Thomas W. Dubensky Jr., Ph.D., is a veteran biopharma executive and entrepreneur with a track record of strategic leadership in both private and public companies, ImmuneSensor said.
MORE